In re Narconon Drug Rehabilitation Marketing, Sales Practices & Products Liability Litigation
This text of 84 F. Supp. 3d 1367 (In re Narconon Drug Rehabilitation Marketing, Sales Practices & Products Liability Litigation) is published on Counsel Stack Legal Research, covering United States Judicial Panel on Multidistrict Litigation primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
ORDER DENYING TRANSFER
Before the Panel:
On the basis of the papers filed and the hearing session held, we conclude that centralization will not serve the convenience of the parties and witnesses or further the just and efficient conduct of this litigation. These actions share some common factual questions relating to plaintiffs’ allegations that the Narconon Program — -a drug rehabilitation program that plaintiffs allege consists solely of the reading of literature from the Scientology religion and a sauna detoxification program — does not meet the applicable standard of care for treating substance abuse and that defendants misrepresented the Narconon program’s efficacy and its connection to Scientology. We are not convinced, though, that these common issues are sufficiently complex or numerous to warrant the creation of an MDL. These actions are primarily fraud actions and will involve significant case-specific facts, such as the specific repre[1368]*1368sentations regarding the Narconon Program made to each plaintiff, the conditions at the different facilities attended by the plaintiffs at different times, and the widely varying injuries allegedly suffered by plaintiffs. The necessary discovery and pretrial practice in each action also will differ from action to action due to the different state and federal laws asserted in each action. In addition, several cases involve arbitration clauses and, to the extent that plaintiffs pose capacity defenses to those clauses, that inquiry will be individualized. Further, the common defendants — ABLE and NI — have been dismissed from at least eight of these actions to date. Thus, on the present record, it appears that individualized facts may predominate over the common factual issues in this litigation. See In re Signal Int’l LLC Human Trafficking Litig., MDL No. 2554, 38 F.Supp.3d 1390, 1390, 2014 WL 4050056, at *1 (J.P.M.L. Aug. 12, 2014) (denying centralization because, inter alia, “individualized facts very well may predominate over the common factual issues alleged by plaintiffs”).
Furthermore, none of the actions is a class action, which limits the scope for inconsistent pretrial rulings and practice to issues pertaining to discovery and scheduling. Plaintiffs in all the actions on the motion are represented by common counsel,2 while defendants purportedly have retained liaison counsel to coordinate the litigation. At oral argument; counsel for the defendants confirmed their willingness to coordinate with respect to discovery of any common third-party or Narconon witnesses. These circumstances suggest that voluntary cooperation and coordination among the parties and the involved courts, particularly given the number of actions, is a preferable alternative to centralization to address any possibility of duplicative discovery or inconsistent pretrial rulings. See, e.g., In re Eli Lilly & Co. (Cephalexin Monohydrate) Patent Litig., 446 F.Supp. 242, 244 (J.P.M.L.1978); see also Manual for Complex Litigation, Fourth, § 20.14 (2004).
IT IS THEREFORE ORDERED that the motion for centralization of these actions is denied.
SCHEDULE A
MDL No. 2598 — IN RE: NARCONON DRUG REHABILITATION MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION
Central District of California
LOVETT v. ASSOCIATION OF BETTER LIVING AND EDUCATION INTERNATIONAL, ET AL., C.A. No. 2:14-06430
NORD-SHAFER, ET AL. v. ASSOCIATION OF BETTER LIVING AND EDUCATION INTERNATIONAL, ET AL., C.A. No. 2:14-06438
Northern District of California
O'CONNELL, ET AL. v. NARCONON OF NORTHERN CALIFORNIA, ET AL. C.A. No. 5:14-02660
Southern District of California
AMATO v. NARCONON FRESH START, ET AL., C.A. No. 3:14-00588 [1369]*1369BURCHETT, ET AL. v. NARCONON FRESH START, ET AL., C.A. No. 3:14-01678
KELLER, ET AL. v. NARCONON FRESH START, ET AL., C.A. No. 3:14-02168
HENNING, ET AL. v. NARCONON FRESH START, ET AL., C.A. No. 3:14-02379
District of Colorado
MOTT, ET AL. v. NARCONON FRESH START, C.A. No. 1:14-01293
MATTHYS, ET AL. v. NARCONON FRESH START, ET AL., C.A. No. 1:14-01304
LEVY v. NARCONON FRESH START, ET AL., C.A. No. 1:14-01591
VAIRO, ET AL. v. NARCONON FRESH START, ET AL., C.A. No. 1:14-02748
COURSON, ET AL. v. NARCONON FRESH START, ET AL., C.A. No. 1:14-02768
District of Nevada
WELCH, ET AL. v. NARCONON FRESH START, C.A. No. 2:14-00167
TARR, ET AL. v. NARCONON FRESH START, C.A. No. 2:14-00283
GEANACOPULOS, ETAL. v. NARCONON FRESH START, ET AL., C.A. No. 2:14-00629
YATES, ET AL. v. NARCONON FRESH START, ET AL., C.A. No. 2:14-00837
WINCHELL, ET AL. v. NARCONON FRESH START, ET AL., C.A. No. 2:14-00851
McCLURE, ET AL. v. NARCONON FRESH START, ET AL., C.A. No. 2:14-00995
TINO, ETAL. v. NARCONON FRESH START, ET AL., C.A. No. 2:14-01083
KOSLOW, ET AL. v. NARCONON FRESH START, ET AL., C.A. No. 2:14-01588
MARTIN, ET AL. v. NARCONON FRESH START, ET AL., C.A. No. 2:14-01599
Judge Lewis A. Kaplan took no part in the decision of this matter.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
84 F. Supp. 3d 1367, 2015 U.S. Dist. LEXIS 14292, 2015 WL 506365, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-narconon-drug-rehabilitation-marketing-sales-practices-products-jpml-2015.